NO20072599L - Inhibitorer av 11-beta-hydroksyl steroid dehydrogenase Type 1 og fremgangsmater for anvendelse derav - Google Patents

Inhibitorer av 11-beta-hydroksyl steroid dehydrogenase Type 1 og fremgangsmater for anvendelse derav

Info

Publication number: NO20072599L
Authority: NO; Norway
Prior art keywords: inhibitors; dehydrogenase type; steroid dehydrogenase; beta; methods
Prior art date: 2004-11-18

Application number

NO20072599A

Other languages

English (en)

Norwegian (no)

Inventor

Wenqing Yao

Jingcong Zhuo

Chunhong He

Original Assignee

Incyte Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-11-18

Filing date

2007-05-22

Publication date

2007-08-15

2007-05-22 Application filed by Incyte Corp filed Critical Incyte Corp

2007-08-15 Publication of NO20072599L publication Critical patent/NO20072599L/no

Links

101710088194 Dehydrogenase Proteins 0.000 title abstract 3
239000003112 inhibitor Substances 0.000 title abstract 2
102000003979 Mineralocorticoid Receptors Human genes 0.000 abstract 2
108090000375 Mineralocorticoid Receptors Proteins 0.000 abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
-1 hydroxyl steroid Chemical class 0.000 abstract 2
PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 abstract 1
PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 abstract 1
229960002478 aldosterone Drugs 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20072599A 2004-11-18 2007-05-22 Inhibitorer av 11-beta-hydroksyl steroid dehydrogenase Type 1 og fremgangsmater for anvendelse derav NO20072599L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62893304P	2004-11-18	2004-11-18
PCT/US2005/041763 WO2006055752A2 (en)	2004-11-18	2005-11-17	INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1 AND METHODS OF USING THE SAME

Publications (1)

Publication Number	Publication Date
NO20072599L true NO20072599L (no)	2007-08-15

Family

ID=36407763

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20072599A NO20072599L (no)	2004-11-18	2007-05-22	Inhibitorer av 11-beta-hydroksyl steroid dehydrogenase Type 1 og fremgangsmater for anvendelse derav

Country Status (12)

Country	Link
US (2)	US20060122210A1 (pt)
EP (1)	EP1824842A4 (pt)
JP (1)	JP2008520700A (pt)
KR (1)	KR20070097441A (pt)
CN (1)	CN101103016A (pt)
AU (1)	AU2005306476A1 (pt)
BR (1)	BRPI0518281A2 (pt)
CA (1)	CA2587153A1 (pt)
IL (1)	IL183088A0 (pt)
MX (1)	MX2007005820A (pt)
NO (1)	NO20072599L (pt)
WO (1)	WO2006055752A2 (pt)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI350168B (en)	2004-05-07	2011-10-11	Incyte Corp	Amido compounds and their use as pharmaceuticals
WO2006012227A2 (en) *	2004-06-24	2006-02-02	Incyte Corporation	Amido compounds and their use as pharmaceuticals
CA2584502A1 (en) *	2004-06-24	2006-01-05	Incyte Corporation	2-methylpropanamides and their use as pharmaceuticals
US8071624B2 (en)	2004-06-24	2011-12-06	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
US20050288317A1 (en) *	2004-06-24	2005-12-29	Wenqing Yao	Amido compounds and their use as pharmaceuticals
WO2006002350A1 (en) *	2004-06-24	2006-01-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
CA2571258A1 (en) *	2004-06-24	2006-01-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
AU2005273986A1 (en) *	2004-08-10	2006-02-23	Incyte Corporation	Amido compounds and their use as pharmaceuticals
ES2547724T3 (es) *	2004-11-10	2015-10-08	Incyte Corporation	Compuestos de lactama y su uso como productos farmacéuticos
US8110581B2 (en) *	2004-11-10	2012-02-07	Incyte Corporation	Lactam compounds and their use as pharmaceuticals
AR056968A1 (es)	2005-04-11	2007-11-07	Xenon Pharmaceuticals Inc	Compuestos espiro-oxindol y composiciones farmacéuticas
AR053710A1 (es)	2005-04-11	2007-05-16	Xenon Pharmaceuticals Inc	Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
WO2007011809A1 (en)	2005-07-19	2007-01-25	Merck & Co., Inc.	Spirochromanone derivatives as acetyl coenzyme a carboxylase (acc) inhibitors
CA2621255A1 (en) *	2005-09-21	2007-04-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
CA2630492C (en) *	2005-12-05	2015-04-14	Incyte Corporation	Spiro-lactam compounds
WO2007084314A2 (en) *	2006-01-12	2007-07-26	Incyte Corporation	MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
AU2007210018A1 (en) *	2006-01-31	2007-08-09	Incyte Corporation	Amido compounds and their use as pharmaceuticals
US20070213311A1 (en) *	2006-03-02	2007-09-13	Yun-Long Li	Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007103719A2 (en) *	2006-03-03	2007-09-13	Incyte Corporation	MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
JP2009535420A (ja) *	2006-05-01	2009-10-01	インサイト・コーポレイション	１１−βヒドロキシルステロイドデヒドロゲナーゼタイプ１のモジュレーターとしてのテトラ置換ウレア
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
EP2018378A2 (en) *	2006-05-17	2009-01-28	Incyte Corporation	Heterocyclic inhibitors of 11-b hydroxyl steroid dehydrogenase type i and methods of using the same
TW200811170A (en)	2006-06-27	2008-03-01	Sanofi Aventis	Urea derivatives of tropane, their preparation and their therapeutic application
FR2902790A1 (fr) *	2006-06-27	2007-12-28	Sanofi Aventis Sa	Derives d'urees de piperidine ou pyrrolidine,leur preparation et leur application en therapeutique
TW200811158A (en) *	2006-06-27	2008-03-01	Sanofi Aventis	Piperidine or pyrrolidine urea derivatives, their preparation and their therapeutic application
WO2008006702A1 (en) *	2006-07-13	2008-01-17	High Point Pharmaceuticals, Llc.	11beta-hydroxysteroid dehydrogenase type 1 active compounds
WO2008060789A2 (en)	2006-10-12	2008-05-22	Xenon Pharmaceuticals Inc.	Use of spiro-oxindole compounds as therapeutic agents
PE20081559A1 (es)	2007-01-12	2008-11-20	Merck & Co Inc	DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
AU2008205642B2 (en)	2007-01-12	2013-06-06	Msd K.K.	Spirochromanon derivatives
US20080306102A1 (en) *	2007-05-18	2008-12-11	Kowa Co., Ltd.	Novel spirooxyindole compounds and drugs containing same
CL2008001839A1 (es)	2007-06-21	2009-01-16	Incyte Holdings Corp	Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
US8222417B2 (en)	2007-06-27	2012-07-17	Taisho Pharmaceutical Co., Ltd	Compound having 11β-HSD1 inhibitory activity
WO2009147188A1 (en)	2008-06-05	2009-12-10	Glaxo Group Limited	Benzpyrazol derivatives as inhibitors of pi3 kinases
ES2383246T3 (es)	2008-06-05	2012-06-19	Glaxo Group Limited	4-amino-indazoles
WO2009147189A1 (en)	2008-06-05	2009-12-10	Glaxo Group Limited	Novel compounds
US20100022572A1 (en)	2008-07-18	2010-01-28	Kowa Company, Ltd.	Novel spiro compound and medicine comprising the same
US8236789B2 (en)	2008-08-29	2012-08-07	Kowa Company, Ltd.	1-adamantyl azetidin-2-one derivatives and drugs containing same
CA2741024A1 (en)	2008-10-17	2010-04-22	Xenon Pharmaceuticals Inc.	Spiro-oxindole compounds and their use as therapeutic agents
JO3032B1 (ar)	2008-10-17	2016-09-05	Xenon Pharmaceuticals Inc	مركبات سبيرو – اوكسندول وإستعمالاتها كعوامل علاجية.
JP5477973B2 (ja)	2008-10-29	2014-04-23	興和株式会社	１，２−ジアゼチジン−３−オン誘導体及びこれを含有する医薬
US8927549B2 (en)	2008-11-21	2015-01-06	High Point Pharmaceuticals, Llc	Adamantyl benzamide derivatives
JP5656880B2 (ja)	2009-03-09	2015-01-21	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール
TW201038572A (en) *	2009-03-25	2010-11-01	Gruenenthal Gmbh	Substituted spiro-amide compounds
LT2899191T (lt)	2009-04-30	2017-10-25	Glaxo Group Limited	Oksazolo pakeistieji indazolai kaip pi3-kinazės inhibitoriai
ES2350077B1 (es)	2009-06-04	2011-11-04	Laboratorios Salvat, S.A.	Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1.
AR077252A1 (es)	2009-06-29	2011-08-10	Xenon Pharmaceuticals Inc	Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
KR20120099429A (ko)	2009-10-14	2012-09-10	제논 파마슈티칼스 인크.	스피로-옥스인돌 화합물의 합성 방법
WO2011106729A2 (en)	2010-02-26	2011-09-01	Xenon Pharmaceuticals Inc.	Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
WO2012015715A1 (en)	2010-07-27	2012-02-02	High Point Pharmaceuticals, Llc	Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
AU2011303597A1 (en)	2010-09-17	2013-04-11	Purdue Pharma L.P.	Pyridine compounds and the uses thereof
GB201018124D0 (en)	2010-10-27	2010-12-08	Glaxo Group Ltd	Polymorphs and salts
US8754114B2 (en)	2010-12-22	2014-06-17	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
RS58514B1 (sr)	2012-06-13	2019-04-30	Incyte Holdings Corp	Supstituisana triciklična jedinjenja kao inhibitori fgfr
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
PH12015502383B1 (en)	2013-04-19	2023-02-03	Incyte Holdings Corp	Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
WO2016127068A1 (en)	2015-02-05	2016-08-11	Teva Pharmaceuticals International Gmbh	Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
TWI712601B (zh)	2015-02-20	2020-12-11	美商英塞特公司	作為fgfr抑制劑之雙環雜環
US9580423B2 (en)	2015-02-20	2017-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
WO2017011788A1 (en) *	2015-07-15	2017-01-19	Cornell University	Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
EP3235813A1 (en)	2016-04-19	2017-10-25	Cidqo 2012, S.L.	Aza-tetra-cyclo derivatives
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
HRP20241288T1 (hr)	2018-05-04	2024-12-06	Incyte Corporation	Čvrsti oblici fgfr inhibitora i postupci za njihovu proizvodnju
AU2019262579B2 (en)	2018-05-04	2024-09-12	Incyte Corporation	Salts of an FGFR inhibitor
US11628162B2 (en)	2019-03-08	2023-04-18	Incyte Corporation	Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en)	2019-07-09	2023-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CA3157361A1 (en)	2019-10-14	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CA3163875A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
JP7832891B2 (ja)	2019-12-04	2026-03-18	インサイト・コーポレイション	Ｆｇｆｒ阻害剤の誘導体
US12012409B2 (en)	2020-01-15	2024-06-18	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2022221170A1 (en)	2021-04-12	2022-10-20	Incyte Corporation	Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
CA3220155A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
US11939331B2 (en)	2021-06-09	2024-03-26	Incyte Corporation	Tricyclic heterocycles as FGFR inhibitors

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2312247A1 (fr) *	1975-05-30	1976-12-24	Parcor	Derives de la thieno-pyridine, leur procede de preparation et leurs applications
US4439606A (en) *	1982-05-06	1984-03-27	American Cyanamid Company	Antiatherosclerotic 1-piperazinecarbonyl compounds
US5206240A (en) *	1989-12-08	1993-04-27	Merck & Co., Inc.	Nitrogen-containing spirocycles
US5852029A (en) *	1990-04-10	1998-12-22	Israel Institute For Biological Research	Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
DE4234295A1 (de) *	1992-10-12	1994-04-14	Thomae Gmbh Dr K	Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
FR2705343B1 (fr) *	1993-05-17	1995-07-21	Fournier Ind & Sante	Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2724656B1 (fr) *	1994-09-15	1996-12-13	Adir	Nouveaux derives du benzopyranne, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2736053B1 (fr) *	1995-06-28	1997-09-19	Sanofi Sa	Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
US7294637B2 (en) *	2000-09-11	2007-11-13	Sepracor, Inc.	Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
WO2003000657A1 (en) *	2001-06-20	2003-01-03	Daiichi Pharmaceutical Co., Ltd.	Diamine derivatives
US6547958B1 (en) *	2001-07-13	2003-04-15	Chevron U.S.A. Inc.	Hydrocarbon conversion using zeolite SSZ-59
US6818772B2 (en) *	2002-02-22	2004-11-16	Abbott Laboratories	Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
GB0213715D0 (en) *	2002-06-14	2002-07-24	Syngenta Ltd	Chemical compounds
EP1553098A1 (en) *	2002-10-18	2005-07-13	Ono Pharmaceutical Co., Ltd.	Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
CN1768041A (zh) *	2003-04-04	2006-05-03	麦克公司	作为黑皮质素－4受体激动剂的酰化螺哌啶衍生物
ATE482747T1 (de) *	2003-04-11	2010-10-15	High Point Pharmaceuticals Llc	Neue amide derivate und deren pharmazeutische verwendungen
JP2007516298A (ja) *	2003-12-23	2007-06-21	アリーナファーマシューティカルズ，インコーポレイテッド	新規なスピロインドリンまたはスピロイソキノリン化合物、それらの使用方法および組成物
TWI350168B (en) *	2004-05-07	2011-10-11	Incyte Corp	Amido compounds and their use as pharmaceuticals
WO2006002350A1 (en) *	2004-06-24	2006-01-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
US8071624B2 (en) *	2004-06-24	2011-12-06	Incyte Corporation	N-substituted piperidines and their use as pharmaceuticals
US20050288317A1 (en) *	2004-06-24	2005-12-29	Wenqing Yao	Amido compounds and their use as pharmaceuticals
WO2006012227A2 (en) *	2004-06-24	2006-02-02	Incyte Corporation	Amido compounds and their use as pharmaceuticals
CA2584502A1 (en) *	2004-06-24	2006-01-05	Incyte Corporation	2-methylpropanamides and their use as pharmaceuticals
CA2571258A1 (en) *	2004-06-24	2006-01-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
AU2005273986A1 (en) *	2004-08-10	2006-02-23	Incyte Corporation	Amido compounds and their use as pharmaceuticals
EP1795527B1 (en) *	2004-09-07	2009-04-22	Banyu Pharmaceutical Co., Ltd.	Carbamoyl-substituted spiro derivative
EP1802623A1 (en) *	2004-10-12	2007-07-04	Novo Nordisk A/S	11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
ES2547724T3 (es) *	2004-11-10	2015-10-08	Incyte Corporation	Compuestos de lactama y su uso como productos farmacéuticos
CN101142172A (zh) *	2005-01-05	2008-03-12	艾博特公司	11-β-羟甾类脱氢酶1型酶的抑制剂
EP1866285A1 (en) *	2005-03-03	2007-12-19	F. Hoffmann-Roche AG	1-sulfonyl-piperdine-3-carboxylic acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus
CA2621255A1 (en) *	2005-09-21	2007-04-05	Incyte Corporation	Amido compounds and their use as pharmaceuticals
CA2630492C (en) *	2005-12-05	2015-04-14	Incyte Corporation	Spiro-lactam compounds
WO2007084314A2 (en) *	2006-01-12	2007-07-26	Incyte Corporation	MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
AU2007210018A1 (en) *	2006-01-31	2007-08-09	Incyte Corporation	Amido compounds and their use as pharmaceuticals
US20070213311A1 (en) *	2006-03-02	2007-09-13	Yun-Long Li	Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007103719A2 (en) *	2006-03-03	2007-09-13	Incyte Corporation	MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME

2005
- 2005-11-17 CN CNA2005800467003A patent/CN101103016A/zh active Pending
- 2005-11-17 EP EP05846492A patent/EP1824842A4/en not_active Withdrawn
- 2005-11-17 MX MX2007005820A patent/MX2007005820A/es not_active Application Discontinuation
- 2005-11-17 BR BRPI0518281-6A patent/BRPI0518281A2/pt not_active IP Right Cessation
- 2005-11-17 US US11/281,648 patent/US20060122210A1/en not_active Abandoned
- 2005-11-17 CA CA002587153A patent/CA2587153A1/en not_active Abandoned
- 2005-11-17 WO PCT/US2005/041763 patent/WO2006055752A2/en not_active Ceased
- 2005-11-17 JP JP2007543257A patent/JP2008520700A/ja not_active Withdrawn
- 2005-11-17 AU AU2005306476A patent/AU2005306476A1/en not_active Abandoned
- 2005-11-17 KR KR1020077013662A patent/KR20070097441A/ko not_active Withdrawn
2007
- 2007-05-09 IL IL183088A patent/IL183088A0/en unknown
- 2007-05-22 NO NO20072599A patent/NO20072599L/no not_active Application Discontinuation
2009
- 2009-01-06 US US12/349,124 patent/US20090298808A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20060122210A1 (en)	2006-06-08
EP1824842A2 (en)	2007-08-29
AU2005306476A1 (en)	2006-05-26
WO2006055752A2 (en)	2006-05-26
MX2007005820A (es)	2007-07-18
US20090298808A1 (en)	2009-12-03
BRPI0518281A2 (pt)	2008-11-18
JP2008520700A (ja)	2008-06-19
EP1824842A4 (en)	2009-08-26
CN101103016A (zh)	2008-01-09
CA2587153A1 (en)	2006-05-26
IL183088A0 (en)	2007-09-20
WO2006055752A3 (en)	2007-07-05
KR20070097441A (ko)	2007-10-04

Legal Events

Date	Code	Title	Description
2011-06-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20072599L (no)	2007-08-15	Inhibitorer av 11-beta-hydroksyl steroid dehydrogenase Type 1 og fremgangsmater for anvendelse derav
NO20070372L (no)	2007-03-08	Amidoforbindelser og anvendelse derav som farmasoytiske preparater
NO20072322L (no)	2007-07-19	Laktamforbindelser og anvendelse derav som farmasoytiske midler
NO20065442L (no)	2006-11-27	Amidoforbindelser og deres anvendelse som legemidler
NO20071048L (no)	2007-05-08	Amidoforbindelser og deres anvendelse som farmasoytika
WO2006002361A3 (en)	2006-05-26	2-methylpropanamides and their use as pharmaceuticals
WO2007038138A3 (en)	2007-07-05	Amido compounds and their use as pharmaceuticals
WO2006012227A3 (en)	2006-05-04	Amido compounds and their use as pharmaceuticals
WO2006012226A3 (en)	2006-07-27	N-substituted piperidines and their use as pharmaceuticals
WO2007067504A3 (en)	2007-11-08	Lactam compounds and methods of using the same
NO20064584L (no)	2006-10-10	Tetrahydropyridoindolderivater
NO20073059L (no)	2007-07-19	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
ATE482213T1 (de)	2010-10-15	Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
NO20082026L (no)	2008-06-25	Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
NO20073628L (no)	2007-07-16	Pyridoner som er nyttige som inhibitorer av kinaser
ATE470443T1 (de)	2010-06-15	Indol-1-yl-essigsäurederivate
CY1108932T1 (el)	2014-07-02	Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
IL179206A0 (en)	2007-03-08	Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
NO20070371L (no)	2007-03-08	N-substituerte piperidiner og anvendelse derav som farmasoytiske preparater
UA89043C2 (ru)	2009-12-25	Амидосоединения и их применение как фармацевтических средств
BRPI0419229A (pt)	2007-12-18	derivados de tiofenopirimidinona substituìdos como inibidores de 17beta-hidroxiesteróide-desidrogenase, uso e composição farmacêutica
UA93036C2 (ru)	2011-01-10	Лактамные соединения и применение в качестве фармацевтических препаратов